IMDX — Insight Molecular Diagnostics Inc.
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1642380 ·
Last close
$3.18
Market Cap
$104.06M
52W High
$8.51
52W Low
$2.42
ADV30
216,873
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 239,000 | 157,000 | -9,088,000 | -11,260,000 | 29,443,000 | 17,756,000 | 50,742,000 |
| Mar 2026 | 32,000 | 15,000 | -10,331,000 | -4,290,000 | 40,427,000 | 28,201,000 | 51,118,000 |
| Dec 2025 | 1,139,000 | 496,000 | -9,950,000 | -22,955,000 | 25,756,000 | 11,583,000 | 57,220,000 |
| Sep 2025 | 260,000 | 139,000 | -7,670,000 | -10,854,000 | 43,937,000 | 18,692,000 | 53,133,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-23,984,000
Investing CF
$-3,491,000
Financing CF
$24,212,000
CapEx
$-3,491,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-1.48
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-405,051,000
Inventory
$382,000
Receivables
$157,000
ST Investments
—
EBIT TTM
$-47,738,000
Pretax Income TTM
$-47,841,000
Interest Exp TTM
$103,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,670,000
EBITDA
$-34,543,000
Free Cash Flow
$-18,789,500
Enterprise Value
$122,310,992
Total Cash
$17,756,000
Total Debt
$2,625,000
Shares Out
32,724,284
Trailing EPS
$-1.52
Book Value
$-0.65
ROE
—
ROA
-57.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,055,000 | -30,578,000 | -50,222,000 | 25,756,000 | 57,220,000 | -31,464,000 | -22,184,000 |
| Dec 2024 | 1,881,000 | -23,247,000 | -60,663,000 | 35,081,000 | 47,355,000 | -12,274,000 | -20,689,000 |
| Dec 2023 | 1,503,000 | -22,417,000 | -27,781,000 | 74,892,000 | 54,424,000 | 20,468,000 | -23,325,000 |
| Dec 2022 | 958,000 | -28,852,000 | -72,902,000 | 100,091,000 | 65,799,000 | 34,292,000 | -45,568,000 |
TTM Snapshot
Revenues TTM
$2,138,000
NetIncome TTM
$-6,671,000
OpCashFlow TTM
$0
Assets (Latest)
$25,756,000
Forward EPS
$-0.80
Max Pain — expiry 2027-03-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $4.00 · spot: $3.18 · call volume: 65 · put volume: 1
Expected Move to 2027-03-19:
±$2.99
(94.03%) —
implied range
$0.19 –
$6.17
· ATM straddle on $4.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MXCT | MAXCYTE, INC. | $119.72M | $1.16 | — |
| ICCC | IMMUCELL CORP /DE/ | $89.73M | $9.88 | — |
| IBAC | IB Acquisition Corp. | $56.59M | $11.30 | — |
| NNNN | Anbio Biotechnology | $267.30M | $6.09 | — |
| ONMD | OneMedNet Corp | $37.53M | $0.63 | — |
News headlines (Yahoo Finance, 1h cache)
iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference
2026-09-02 12:00 · Yahoo
Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript
2026-08-17 21:28 · Yahoo
Oncocyte Eyes Faster, Less Invasive Heart Transplant Rejection Testing
2026-08-17 18:02 · Yahoo
Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing
2026-08-11 20:05 · Yahoo
Breakthrough Science Meets Market Skepticism: Insight Molecular Diagnostics Inc. (IMDX)’s Defining Moment
2026-06-19 18:17 · Yahoo
IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation
2026-06-11 20:17 · Yahoo
How Insight Molecular Diagnostics (IMDX) Story Is Shifting With Fresh Capital And GraftAssureDx Submission
2026-05-15 13:16 · Yahoo
Insight Molecular Diagnostics Inc (IMDX) Q1 2026 Earnings Call Highlights: Strategic Advances ...
2026-05-14 05:00 · Yahoo
IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
2026-08-10 20:05 · Yahoo
Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio
2026-07-16 19:22 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.